disease burden phenotype
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (9)
Papers in which this entity is mentioned.
- Genome-wide association testing beyond SNPs. (2025)
- Principles and methods for transferring polygenic risk scores across global populations. (2024)
- Predicting tumour content of liquid biopsies from cell-free DNA. (2023)
- Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
- Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma. (2022)
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
- Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors. (2018)
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. (2018)
- Clinical whole-exome sequencing for the diagnosis of mendelian disorders. (2013)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| disease burden | phenotype | 14 | 24 |
| dalys | phenotype | 2 | 4 |
| burden of disease | phenotype | 1 | 1 |
| global disease burden | phenotype | 1 | 1 |